Expatriates, without an official permit, banned from entering Makkah
MAKKAH — The Directorate of Public Security has announced that expatriates, without an official permit, are banned from entering Makkah, effective from Wednesday, April 23.
The directorate stated that those residents who hold one of the following documents will be exempted from this ban: a work permit or a residency permit (iqama) issued in Makkah, or a Hajj permit. Expatriates without the required permits will be turned back from the security checkpoints at the entry points of Makkah.
The enforcement of this regulation aims to regulate access to Makkah during the Hajj season and ensure smooth movement and security for pilgrims. Permits for entering Makkah during the Hajj season are issued electronically through the 'Absher Individuals' platform and the 'Muqeem' portal, in coordination with the unified digital platform for Hajj permits, 'Tasreeh.'
The Ministry of Interior also renewed its warning that it is prohibited to enter or stay in the city of Makkah for holders of all types of visas, with the exception of those arriving with a Hajj visa, starting next Tuesday, April 29.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
a day ago
- Arab News
Designated banks stay open today as Pakistan receives Hajj applications on final day
ISLAMABAD: Designated banks across Pakistan are open today for the receipt of Hajj applications from intending pilgrims under the government scheme, according to the Pakistani religious affairs ministry. Pakistan has a Hajj quota of 179,210 pilgrims. Of this, 129,210 seats have been allocated for the government scheme and the rest for private tour operators. The religious affairs ministry this week said it had received 91,000 applications under the government scheme. The religious affairs ministry said the State Bank of Pakistan accepted its request and issued orders to keep open branches of 14 designated banks for the receipt of Hajj applications on the final day. Pakistan began receiving Hajj applications on Aug. 4. 'Bookings will be closed once the required number of applicants is reached,' the ministry said. 'Hajj applications received on a first-come, first-served basis will be considered valid.' It urged Hajj applicants to obtain a computerized receipt from the bank and check their details on the ministry's online portal or Pak Hajj 2026 app. 'In case of any mistake, get it corrected immediately by the concerned bank,' the ministry added. Under the government scheme, pilgrims can choose between a long Hajj package (38–42 days) and a short package (20–25 days). The estimated cost of the government Hajj package ranges between Rs1,150,000 and Rs1,250,000 (approximately $4,050 to $4,236). 'It is mandatory to submit the first installment of Rs500,000 or Rs550,000 along with the application according to the package,' the ministry said this week. 'The second installment of Hajj dues will be collected from November 1.' Saudi Arabia approved the same overall quota for Pakistan in 2025, but a significant portion of the private allocation went unused due to delays by tour operators in meeting payment and registration deadlines, while the government fulfilled its share of over 88,000 pilgrims. Private operators blamed the shortfall on technical issues, including payment processing and communication problems.
Saudi Gazette
3 days ago
- Saudi Gazette
SFDA publishes guidelines for travelers to obtain clearance permit for controlled drugs
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has outlined the procedures for obtaining a clearance permit for controlled drugs containing narcotics and psychotropic substances in the possession of passengers arriving in or departing from Saudi Arabia. This reinforces SFDA's commitment to facilitating patients' travel and ensuring a smoother journey while maintaining safety standards. SFDA confirms that all information related to controlled drug permits is available through its Controlled Drug System (CDS) at Travelers can now easily apply for a permit through the CDS platform by creating a personal account, submitting an electronic clearance permit request with the patient's details and trip information, and uploading supporting documents like a prescription, medical report, and proof of identity. Travelers can also add multiple medications by providing accurate details, including the trade name, active ingredient, drug concentration, dosage form, and quantity or pack size. Applicants must include documents that prove the medical need for the medication, whether it is for the traveler or another patient. The applicant must agree to the terms and conditions, and then submit the application. Travelers can also track the status of the application, which is clearly classified as "Submitted," "Completed," "Rejected," or "Incomplete." The applicant can take the printout of the permit once the application is completed. This guideline highlights SFDA's role in regulating the entry and exit of controlled drugs, protecting patient rights, and preventing misuse. It provides a convenient and secure way for traveling patients to get the clearances they need, allowing them to submit requests at any time and from any location, which eliminates the need for additional procedures. For a step-by-step guide on how to obtain a clearance permit for controlled drugs, travelers can refer to the User Manual for the Traveler Clearance Permit of Controlled Drugs on SFDA website:
Saudi Gazette
3 days ago
- Saudi Gazette
SFDA publishes guidelines for travelers to obtain clearance permit for controlled drugs
Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has outlined the procedures for obtaining a clearance permit for controlled drugs containing narcotics and psychotropic substances in the possession of passengers arriving in or departing from Saudi Arabia. This reinforces SFDA's commitment to facilitating patients' travel and ensuring a smoother journey while maintaining safety standards. SFDA confirms that all information related to controlled drug permits is available through its Controlled Drug System (CDS) at Travelers can now easily apply for a permit through the CDS platform by creating a personal account, submitting an electronic clearance permit request with the patient's details and trip information, and uploading supporting documents like a prescription, medical report, and proof of identity. Travelers can also add multiple medications by providing accurate details, including the trade name, active ingredient, drug concentration, dosage form, and quantity or pack size. Applicants must include documents that prove the medical need for the medication, whether it is for the traveler or another patient. The applicant must agree to the terms and conditions, and then submit the application. Travelers can also track the status of the application, which is clearly classified as "Submitted," "Completed," "Rejected," or "Incomplete." The applicant can take the printout of the permit once the application is completed. This guideline highlights SFDA's role in regulating the entry and exit of controlled drugs, protecting patient rights, and preventing misuse. It provides a convenient and secure way for traveling patients to get the clearances they need, allowing them to submit requests at any time and from any location, which eliminates the need for additional procedures. For a step-by-step guide on how to obtain a clearance permit for controlled drugs, travelers can refer to the User Manual for the Traveler Clearance Permit of Controlled Drugs on SFDA website:
